PROF vs SRPT · rev $10.7M vs rev $1.90B
Profound Medical Corp (PROF) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
PROF currently screens at market cap $238.7M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PROF and SRPT stock pages for the full models.
Not investment advice.